Dynamic changes in WIfI classification as a prognostic indicator for midterm outcomes in CLTI patients undergoing infrapopliteal endovascular revascularization

WIfI 分级动态变化作为接受膝下血管内血运重建术的 CLTI 患者中期预后的指标

阅读:1

Abstract

OBJECTIVE: This study aimed to evaluate the prognostic significance of early postoperative the Wound, Ischemia, and foot Infection (WIfI) stage changes in Chronic limb-threatening ischemia (CLTI) patients with infrapopliteal lesions undergoing endovascular revascularization. METHODS: A total of 153 patients with infrapopliteal occlusive CLTI who underwent endovascular revascularization were prospectively enrolled. WIfI staging was performed preoperatively and reassessed within 1-3 days after the operation. Patients were categorized into two groups based on postoperative WIfI stage changes: the "WIfI-Improved Group" (postoperative WIfI stage improved by at least one level) and the "WIfI-Non-Improved Group" (no change or worsening in postoperative WIfI stage). Clinical outcomes, including major adverse events (MAEs), amputation-free survival (AFS), mortality, and major adverse limb events (MALEs), were assessed at 1 year postoperatively. RESULTS: There were no statistically significant differences between the two groups in terms of demographic data and underlying comorbidities. Patients in the WIfI-Improved Group exhibited significantly lower risks of MAEs (Log-rank, P = 0.011), improved AFS (P = 0.011), and reduced mortality (P = 0.005) compared to the WIfI-Non-Improved Group. However, no statistically significant differences in MALEs were observed between the two groups (P = 0.209). CONCLUSIONS: Postoperative improvement in WIfI classification is a strong predictor of better 1-year outcomes, including reduced MAEs, improved AFS, and lower mortality, in CLTI patients undergoing infrapopliteal endovascular revascularization. Dynamic WIfI assessment can serve as a valuable tool for postoperative prognosis evaluation, risk stratification, and guiding individualized management strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。